Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

11 trials with published results (17%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.8%

5 terminated out of 64 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

6%

4 trials in Phase 3/4

Results Transparency

28%

11 of 40 completed with results

Key Signals

11 with results89% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (16)
P 1 (7)
P 2 (3)
P 4 (4)

Trial Status

Completed40
Unknown10
Recruiting8
Terminated5
Enrolling By Invitation1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 40 completed trials

Clinical Trials (64)

Showing 20 of 20 trials
NCT05348564Not ApplicableRecruitingPrimary

Comparing Direct vs Indirect Methods for Cascade Screening

NCT00335036Not ApplicableTerminated

Pediatric Lead Extractability and Survival Evaluation (PLEASE)

NCT04675788Phase 4CompletedPrimary

Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening

NCT03775954Recruiting

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

NCT06546137Recruiting

National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

NCT04336644Not ApplicableRecruiting

Continuous Versus Intermittent cARdiac Electrical moNitorinG

NCT07233421Not ApplicableEnrolling By InvitationPrimary

Frequency of Hypoglycemia in Children With Beta-blocker Treated Long QT-syndrome

NCT05274646CompletedPrimary

Impact on Risk Stratification of Overlap Syndrome Phenotype in Patients With E1784K Mutation in SCN5A

NCT05964322CompletedPrimary

Cardiac Rehabilitation of Children and Adolescent With Long QT Syndrome

NCT05906732Phase 1TerminatedPrimary

Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2).

NCT03834883Phase 4CompletedPrimary

Reducing the Risk of Drug-Induced QT Interval Lengthening in Women

NCT04328376Not ApplicableCompletedPrimary

Measurement of the Electromechanical Window to Improve the Diagnosis of Congenital Long QT Syndrome

NCT06661278RecruitingPrimary

Evaluation of Exercise Testing and Physical Activity in Children and Adolescents Living With Inherited Arrhythmias

NCT06087367RecruitingPrimary

Building of a Diagnostic/Prognostic Database for Human ERG Variant Effects

NCT06887387RecruitingPrimary

Wearable Devices for Patient Monitoring in Long QT Syndrome

NCT04581408Phase 2CompletedPrimary

Mutation-specific Therapy for the Long QT Syndrome

NCT04712136Not ApplicableCompletedPrimary

Healthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations

NCT05521451Recruiting

Clinical Cohort Study - TRUST

NCT06375863Not ApplicableCompleted

QT Changes in Geriatric Patients: a Comparison of Spinal and General Anesthesia

NCT03182777Not ApplicableCompleted

Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies

Scroll to load more

Research Network

Activity Timeline